Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Unknown 42Completed 25Recruiting 21Not yet recruiting 10Withdrawn 8Terminated 6Active not recruiting 4Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 3Gynecologic 1

Conditions

Nasopharyngeal Carcinoma 2Uterine Cervical Neoplasms 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 436Carboplatin 321Nivolumab 287Cyclophosphamide 280Specimen Handling 257Cisplatin 251Paclitaxel 248Magnetic Resonance Spectroscopy 248Radiotherapy 217Gemcitabine 180Dexamethasone 180Biopsy 177durvalumab 166atezolizumab 148Rituximab 138Lenalidomide 134Doxorubicin 134Docetaxel 130Bevacizumab 129Ipilimumab 125Radiation 118Capecitabine 117Pemetrexed 112Oxaliplatin 112Etoposide 111Radiosurgery 108Fluorouracil 108venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × nimotuzumab × Clear all
NCT04456322 2025-05-14

Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Active not recruiting
381 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT06879691 2025-03-17

A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell Carcinoma

Biotech Pharmaceutical Co., Ltd.

Phase 4 Active not recruiting
171 enrolled
Head & Neck

Head and Neck Neoplasms

NCT04223024 2025-03-05

Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 2 Active not recruiting
246 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT06771596 2025-01-13

CC11

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Active not recruiting
43 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡